Thomas Shenk By Natalie Morrison 09-Feb-2012 - Last updated on 09-Feb-2012 at 15:34 GMT Facebook Twitter Linkedin Email to a friend The Princeton University Elkins professor, who works in the department of molecular biology, will now focus on forming a new company to commercialise the antiviral discoveries he has made in the college’s lab.He first joined Merck’s board in 2001. Scott Neff, VP of business development for Icon Thomas Shenk, retiring from Merck’s board of directors Iyiola Obayomi, senior director for Ogilvy CommonHealth Lisa Rosselli, senior interactive developer at AbelsonTaylor Chandana Reddy, interactive developer at AbelsonTaylor Jürgen Frisch, new chief medical officer of European operations at Clinipace Prev 1 2 3 4 5 6 Next